InterCure Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

5.50$ +0.6% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

InterCure Ltd. (INCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 691 million ILS. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

Tick rows to compare them in a chart (up to 4)

Balance Sheet INCR
Line item	Q1 16	Q2 16	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26
Total Assets	17	17	19	28	25	24	25	24	21	21	36	36	71	293	71	282	241	258	321	326	343	588	656	686	744	793	875	876	876	842	787	741	741	763	763	752	752	691	691	691
Current Assets	2.8	2.3	1.8	3.3	1.2	1.2	2.6	2.5	1.9	1.9	5.0	5.0	3.7	60	11	42	34	46	80	77	83	287	312	336	374	417	490	426	426	395	419	371	371	392	392	374	374	317	317	317
Cash	1.9	1.4	1.0	2.8	0.7	0.7	2.2	2.1	0.9	1.6	3.4	3.4	-3.7	51	6.8	27	17	8.6	48	38	41	201	209	196	210	221	215	106	106	103	101	20	20	79	78	51	51	46	46	46
Cash & Short-Term Investments	2.8	2.2	1.7	3.3	1.2	1.1	2.6	2.4	0.9	1.9	3.7	3.7	3.7	51	6.9	28	17	8.8	48	38	41	201	209	197	210	222	215	107	107	103	101	20	20	79	–	52	52	47	–	47
Receivables	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	1.3	2.2	1.0	2.2	6.6	8.3	15	16	15	21	42	51	38	49	27	115	58	169	134	61	62	62	52	52	47	47	22	21	154
Inventory	0.0	-0.1	-0.1	0.0	0.0	0.0	-0.3	-0.4	-1.2	-1.9	-0.6	-1.5	1.4	4.6	1.4	5.8	7.9	11	16	22	21	43	52	68	93	91	135	136	136	144	105	126	130	120	125	148	148	108	108	108
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	50	53	64	69	82	87	89	93	95	–	101	97	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	42	168	42	168	168	168	190	190	190	227	255	258	274	279	285	284	284	284	221	224	224	225	225	225	225	219	219	219
Intangible Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.1	0.1	0.1	–	–	–	–	–	–	–	–	–	–
Total Liabilities	3.1	3.1	3.3	3.7	4.9	4.7	3.4	3.3	4.3	4.3	16	16	6.5	18	6.5	26	28	42	39	34	44	144	205	227	259	291	361	353	353	314	330	279	279	365	365	320	320	294	294	294
Current Liabilities	3.1	3.1	3.3	3.7	4.9	4.7	3.4	3.3	4.3	4.3	16	16	5.7	17	5.7	23	25	40	35	30	35	91	164	194	224	223	295	233	233	208	226	209	209	227	227	202	202	214	214	214
Short-Term Debt	2.5	2.6	2.7	2.4	3.3	3.2	3.1	2.9	4.3	3.4	13	13	3.5	13	3.5	14	15	14	15	1.7	2.4	13	55	76	91	94	136	77	77	57	93	82	82	74	–	63	63	104	–	104
Accounts Payable	0.1	0.1	0.1	0.4	0.0	–	0.0	0.3	0.1	–	0.2	0.2	1.2	2.2	1.2	4.9	3.8	11	15	19	20	41	53	64	83	84	98	99	99	105	78	83	83	78	78	91	91	68	68	68
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.4	0.3	0.6	0.5	36	12	12	15	–	46	100	96	84	–	–	51	–	114	–	–	–	59	–
Shareholders' Equity	14	14	16	24	20	20	22	21	17	17	20	20	20	275	64	256	212	215	264	275	281	427	430	448	462	479	490	503	503	509	455	460	460	397	397	431	431	397	397	397
Retained Earnings	-133	-137	-133	-137	-131	-126	-135	-129	-37	-140	-148	-148	-38	-122	-38	-151	-198	-199	-200	-191	-189	-182	-183	-186	-173	-157	-150	-141	-141	-137	-204	-205	-205	-278	-278	-280	-280	-315	-315	-315
Shares Outstanding	2.3	2.1	2.3	2.6	3.5	3.5	3.3	3.3	3.3	3.1	3.9	3.9	4.7	4.7	4.8	4.9	4.9	4.9	5.0	5.1	8.2	8.2	8.2	43	7.4	9.2	9.1	45	8.6	8.6	9.0	9.6	9.6	8.8	47	11	11	10	55	10

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings